Yi Qin

Beijing Capital Land Ltd. operates as an investment holding company. It provides real estate development and investment services. The firm develops real estate projects, including residences, office buildings, commercial projects, hotels and land development. It operates through the following segments: Beijing, Huadong, Tianjin, Chengyu, Other, Outlets business, Other Investment Real Estate and Primary Land Development. The Beijing segment engages in real estate development, sales and related business in Beijing region. The Huadong segment engages in real estate development, sales and related business in East China. The Tianjin segment engages in real estate, sales and related business in Tianjin region. The Chengyu segment engages in real estate development, sales and related business in Chengdu and Chongqing area. The Other segment engages in real estate development, sales and related business in other regions, including Shenyang, Xi'an, Jiangsu, Zhejiang, and Hainan. The Outlets Business segment engages in the operation and development of first outlet complex in different regions. The Other Investment Real Estate segment engages in the operation and development of non-first outlet investment real estate. The Primary Land Development segment engages in the land development and shantytown reconstruction business in the Beijing, Tianjin and Hebei region. The company was founded on July 23, 2002 and is headquartered in Beijing, China.

Beijing Saike Pharmaceutical Co. Ltd. is a private company that manufactures and sells pharmaceutical products. The company is based in Beijing, China.

Beijing Capital City Development Group Co., Ltd. is an investment services provider. The private company was founded in 2021 and is based in Beijing, China. It is ultimately controlled by the City of Beijing.